- Title
- Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies (vol 33, pg 2315, 2019)
- Creators
- Jinqi Huang - Scripps Research InstituteStepanov Alexey - Russian Academy of SciencesJian Li - Xiamen UniversityTerri Jones - Scripps Research InstituteGeramie Grande - Scripps Research InstituteLacey Douthit - Scripps Research InstituteJun Xie - Xiamen UniversityDanna Chen - Putian UniversityXiaolei Wu - ProteinT Biotechnology Ltd. Co. Tianjin Airport Free Trade Zone, Tianjin, China.Maschan Michael - Federal ReserveChangchun Xiao - Scripps Research InstituteJiangning Zhao - Xiamen UniversityXuehua Xie - Department of Oncology, The first hospital of Putian City, Putian, 351100, Fujian, China.Jia Xie - Scripps Research InstituteXiao Lei Chen - Xiamen UniversityGuo Fu - Xiamen UniversityGabibov Alexander - Russian Academy of SciencesChi-Meng Tzeng - Nanjing Tech University
- Publication Details
- Leukemia, Vol.33(9), pp.2341-2341
- Publisher
- Springer Nature
- Number of pages
- 1
- Academic Unit
- A&S - Chemistry; College of A&S
- Language
- English
- Resource Type
- Journal article
- PMID
- 31097784
- Record Identifier
- 991031713486102976
Journal article
Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies (vol 33, pg 2315, 2019)
Leukemia, Vol.33(9), pp.2341-2341
2019-09-01
PMID: 31097784
Metrics
4 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.130 Lymphomas
- 1.130.1676 Mycosis Fungoides
- Web Of Science research areas
- Hematology
- Oncology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites